FDA panel backs Schering-Plough cancer drug
Monday, October 5, 2009 - 10:56
in Health & Medicine
GAITHERSBURG, Md. (AP) -- Federal health advisers have voted 6-4 that the potential benefits of a Schering-Plough drug used to treat late-stage skin cancer outweigh its toxic risks....
Read the whole article on AP Health
More from AP Health
Related
- New therapy for heart failureThu, 16 Oct 2008, 9:02:20 EDT
- Prodrug could help curb skin toxicity related to EGFR-inhibiting cancer drugsTue, 1 Sep 2009, 12:37:28 EDT
- Broccoli compound targets key enzyme in late-stage cancerWed, 3 Dec 2008, 10:34:05 EST
- USC study finds that green tea blocks benefits of cancer drugTue, 3 Feb 2009, 16:57:48 EST
- Topical cream studied as way to treat skin cancer without the knifeTue, 28 Apr 2009, 19:36:55 EDT